Ethiopia vs Timor-Leste: Prevalence rate of obesity in adults
Ethiopia
2.9%
in 2024
Timor-Leste
3.6%
in 2024
Ethiopia rank
198th
Timor-Leste rank
197th
Prevalence rate of obesity in adults over time
- Ethiopia
- Timor-Leste
How they compare
Timor-Leste currently reports 3.6% against 2.9% in Ethiopia, a difference of 0.7%.
That makes Timor-Leste's figure about 1.2 times Ethiopia's.
The two have swapped places 1 time across 45 shared years of data; in 1980 it was Ethiopia ahead.
Ethiopia ranks 198th and Timor-Leste ranks 197th of 199 countries.
Across the 5 decades both report, Ethiopia averaged higher in 4 and Timor-Leste in 1.
Head to head by decade
| Decade | Ethiopia | Timor-Leste | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 0.3% | 0.2% | 0.1% | Ethiopia |
| 1990s | 0.5% | 0.4% | 0.1% | Ethiopia |
| 2000s | 0.9% | 0.7% | 0.2% | Ethiopia |
| 2010s | 1.7% | 1.6% | 0.1% | Ethiopia |
| 2020s | 2.6% | 3.1% | 0.5% | Timor-Leste |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of obesity in adults, Ethiopia or Timor-Leste?
- Timor-Leste, at 3.6% against 2.9% in Ethiopia as of 2024.
- What is the difference in prevalence rate of obesity in adults between Ethiopia and Timor-Leste?
- 0.7%, with Timor-Leste ahead.
- How many years of comparable data are there for Ethiopia and Timor-Leste?
- 45 years are reported by both, from 1980 to 2024.
- How do Ethiopia and Timor-Leste rank globally for prevalence rate of obesity in adults?
- Ethiopia ranks 198th and Timor-Leste ranks 197th of 199 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of obesity in adults. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated prevalence of obesity in adults, based on general population surveys and statistical modeling. Obesity is a risk factor for chronic complications, including cardiovascular disease, and premature death.